← Open Payments lookup

CIARA VEAL: Open Payments

NPI 1558726778 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,375 in 213 payments from 20 companies in 2025. Trend: 2023 $5,040 · 2024 $4,970 · 2025 $4,375

Food & beverage: $4,339Education: $36
CompanyPaymentsAmount
ABBVIE INC.39$742
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)29$667
Corium, LLC18$396
Bausch Health US, LLC15$306
Tris Pharma Inc18$284
Alkermes, Inc.14$278
Janssen Pharmaceuticals, Inc10$259
Supernus Pharmaceuticals, Inc.15$240
E.R. Squibb & Sons, L.L.C.9$238
Axsome Therapeutics, Inc.11$226

Products named: VRAYLAR, CAPLYTA, Azstarys, REXULTI, Dyanavel XR, APLENZIN, ARISTADA, COBENFY.

Industry payments across TX — which companies pay providers there.